4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0000950170-24-011879
President and CEO sold 100,000 shares at an average $16.56 ($1,656,085)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harris Todd President and CEO | 2024-02-02 | Sale 10b5-1 | −78,996 | $16.45 | $1,299,160 | 1,523,701 | D |
| Harris Todd President and CEO | 2024-02-02 | Sale 10b5-1 | −7,187 | $17.04 | $122,495 | 1,516,514 | D |
| Harris Todd President and CEO | 2024-02-05 | Sale 10b5-1 | −13,817 | $16.97 | $234,430 | 1,502,697 | D |
| Open-market sales · 100,000 sh · avg $16.56 · $1,656,085 | |||||||
Loading xslF345X05/ownership.xml…